Divalproex to divalproex extended release conversion

Clinical Drug Investigation

Volumn 24, Issue 9, 2004, Pages 495-508

  Dutta, Sandeep ^a   Reed, Ronald C ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEPAKOTE ER; VALPROATE SEMISODIUM;

AREA UNDER THE CURVE; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG FORMULATION; DRUG MONITORING; ENTERIC COATED TABLET; EPILEPSY; EXTENDED RELEASE FORMULATION; FOOD DRUG INTERACTION; HUMAN; META ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TIME;

EID: 4644271727     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200424090-00001     Document Type: Article

References (19)

1. Depakote® Tablets Product Information. Divalproex sodium delayed-release tablets. North Chicago (IL): Abbott Laboratories Inc, 2002
2. Depakote® ER Tablets Product Information. Divalproex sodium extended-release tablets. North Chicago (IL): Abbott Laboratories Inc, 2003
3. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261 (22): 3273-7
4. Doughty J, Baker GA, Jacoby A, et al. Compliance and satisfaction with switching from an immediate-release to sustained-release formulation of valproate in people with epilepsy. Epilepsy Behav 2003; 4 (6): 710-6
5. Riva R, Albani F, Cortelli P, et al. Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients. Ther Drug Monit 1983; 5 (2): 191-6
6. Bauer LA, Davis R, Wilensky A, et al. Diurnal variation in valproic acid clearance. Clin Pharmacol Ther 1984; 35 (4): 505-9
7. Loiseau P, Cenraud B, Levy RH, et al. Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients. Clin Pharmacokinet 1982; 7 (6): 544-52
8. Patel IH, Venkataramanan R, Levy RH, et al. Diurnal oscillations in plasma protein binding of valproic acid. Epilepsia 1982; 3 (3): 283-90
9. Ohdo S, Nakano S, Ogawa N. Circadian changes of valproate kinetics depending on meal conditions in humans. J Clin Pharmacol 1992; 32: 822-6
10. Hussein Z, Mukherjee D, Lamm J, et al. Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation. J Clin Pharmacol 1994; 34: 754-9
11. Cavanaugh JH, Granneman R, Lamm J, et al. Effect of food on the bioavailability of a controlled-release formulation of Depakote under multiple-dose conditions [abstract]. Epilepsia 1997; 38 (Suppl. 8): 54
12. Dutta S, Reed RC. Divalproex to divalproex-ER dose conversion: analysis of five distinct studies and dosing recommendations. AAPS Pharm Sci 2003; 4 (4): Abstract W5223 [online]. Available from URL: http://www.aapspharmsci.org/ [Accessed 14 June 2004]
13. Samara E, Granneman R, Achari R, et al. Bioavailability of a controlled-release formulation of Depakote [abstract]. Epilepsia 1997; 38 Suppl. 8: 102
14. Chadwick DW. Concentration-effect relationships of valproic acid. Clin Pharmacokinet 1985; 10 (2): 155-63
15. Dutta S, Zhang Y, Selness DS, et al. Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the divalproex sodium delayed-release formulation in healthy volunteers. Epilepsy Res 2002; 49(1): 1-10
16. Sommerville KW, Dutta S, Biton V, et al. Bioavailability of a divalproex sodium extended-release formulation versus divalproex sodium delayed-release tablet formulation in adult patients on enzyme-inducing antiepileptic drugs. Clin Drug Invest 2003; 23 (10): 661-70
17. Dutta S, Zhang Y, Sommerville KW. Bioavailability (F) of divalproex sodium extended release (ER) tablets relative to divalproex sodium delayed release (DR) tablets: a meta-analysis [abstract]. Clin Pharmacol Ther 2003; 73 (2): P79
18. Fischer JH, Barr AN, Paloucek FP, et al. Effect of food on the serum concentration profile of enteric-coated valproic acid. Neurology 1988; 38 (8): 1319-22
19. Dutta S, Reed RC, Cavanaugh J. Absolute bioavailability and absorption characteristics of divalproex sodium extended-release tablets in healthy volunteers. J Clin Pharmacol 2004; 44: 737-42